Wedgewood Pharmacy Now Compounds Implantable Cisplatin Beads Using Matrix III Under Exclusive License from Royer Animal Health

Cisplatin beads using the Matrix III drug-delivery technology are 1.6mg each and dispensed three beads per vial for $75. Each of the spherical beads is about 3mm in diameter.

In common veterinary practice, cisplatin is injected directly into tumors in an emulsion of sterile sesame oil. Using the implantable bead-form of cisplatin may reduce the veterinarian’s exposure to the highly toxic medication, compared with the injection emulsion, while providing local therapy.

George J. Malmberg, R.Ph., F.A.C.A., F.A.C.V.P, the pharmacist president and CEO of Wedgewood Pharmacy said: “This new alliance with Royer Animal Health combines that company’s proprietary drug delivery technology with our stringent standards for preparing custom-made compounded medicines, which we believe will be of significant value to veterinarians.”

Dr. Gar Royer, CEO of Royer Animal Health added, “We have enormous confidence in the quality standards at Wedgewood Pharmacy, which is one of the largest compounding pharmacies in the nation. Its procedures comply with the strict USP <795> and <797> standards and every compounded preparation undergoes at least five pharmacist-checks before it is dispensed. Wedgewood Pharmacy is known nationally for the consistency of the medications it prepares.”

ABOUT WEDGEWOOD PHARMACY

Wedgewood Pharmacy is one of the largest compounding pharmacies in the United States, providing more than 25,000 prescribers with compounds for their human and veterinary patients. A compounding pharmacy creates customized preparations for individual patients in response to a licensed practitioner’s prescription. It is located in Swedesboro NJ and licensed in most states.

For additional information about the compounding pharmacy profession, visit the International Academy of Compounding Pharmacists’ Web site at ICAPRx.org and CompoundingFacts.org.

ABOUT ROYER ANIMAL HEALTH

Royer Animal Health, LLC, is a wholly owned subsidiary of Royer Biomedical, Inc. Since 1997, Royer Biomedical has developed patented technologies that provide medical professionals with localized, controlled release of approved drugs over a broad range of time spans. Royer Biomedical has developed novel drug-delivery technology platforms offering significant advantages over other chemical matrix systems and techniques.

Wedgewood Pharmacy
Marcy Kelly
Vice President, Marketing
856-832-1303
mkelly@WedgewoodPharmacy.com
or
Heather Flitcraft
Communications Specialist
856-832-1392
hflitcraft@WedgewoodPharmacy.com